Work

482 in Vitro Combination Therapy With Tegobuvir (gs-9190) Is Highly Efficient in Curing Cells From Hcv Replicon and in Delaying/preventing the Development of Antiviral Resistance

Year: 2011

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(11)60484-4

Authors: I. Vliegen, L. Delang, J. Paeshuyse, I.-H. Shih, G. Pürstinger, S. Bondy, W.A. Lee, W. Zhong, J. Neyts

Institutions: Baylor College of Medicine, University Hospital Frankfurt, University Hospital Cologne, Merck & Co., Inc., Rahway, NJ, USA (United States), University Medical Center Freiburg, University Hospital Heidelberg, Vall d'Hebron Hospital Universitari

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2052099897

FWCI: 0.203

Cites:

Cited by: 1

Related to: 10